Literature DB >> 35135096

Significant Clinical Response to a MEK Inhibitor Therapy in a Patient With Metastatic Melanoma Harboring an RAF1 Fusion.

Kevin B Kim1, Thomas Semrad1, Alexa B Schrock1, Siraj M Ali1, Jeffrey S Ross1, Mark Singer1, Mohammed Kashani-Sabet1.   

Abstract

Entities:  

Year:  2018        PMID： 35135096     DOI： 10.1200/PO.17.00138

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN： 2473-4284


× No keyword cloud information.
  1 in total

1.  Transcriptional Profiling of Malignant Melanoma Reveals Novel and Potentially Targetable Gene Fusions.

Authors:  Sourat Darabi; Andrew Elliott; David R Braxton; Jia Zeng; Kurt Hodges; Kelsey Poorman; Jeff Swensen; Basavaraja U Shanthappa; James P Hinton; Geoffrey T Gibney; Justin Moser; Thuy Phung; Michael B Atkins; Gino K In; Wolfgang M Korn; Burton L Eisenberg; Michael J Demeure
Journal:  Cancers (Basel)       Date:  2022-03-15       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.